PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'NHC Key Laboratory of Systems Biology of Pathogens and Christophe Mérieux Laboratory, Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.\', \'Key Laboratory of Respiratory Disease Pathogenomics, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.\', \'Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing, China.\', \'Institute of Respiratory Medicine, Chinese Academy of Medical Science, National Clinical Research Center for Respiratory Diseases, National Center for Respiratory Diseases, Beijing, China.\', \'Jin Yin-tan Hospital; Wuhan, Hubei Province, China.\', \'Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.\', \'Tsinghua University School of Medicine, Beijing, China.\', \'Peking Union Medical College, Beijing, China.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/cid/ciaa1247
?:doi
?:hasPublicationType
?:journal
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
is ?:pmid of
?:pmid
?:pmid
  • 32840287
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Antibody Responses and Clinical Outcomes in Adults Hospitalized With Severe Coronavirus Disease 2019 (COVID-19): A Post hoc Analysis of LOTUS China Trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all